AAAAAA
Results: 1-25/31
Authors:
KNOPP RH
ALAGONA P
DAVIDSON M
GOLDBERG AC
KAFONEK SD
KASHYAP M
SPRECHER D
SUPERKO HR
JENKINS S
MARCOVINA S
Citation: Rh. Knopp et al., EQUIVALENT EFFICACY OF A TIME-RELEASE FORM OF NIACIN (NIASPAN) GIVEN ONCE-A-NIGHT VERSUS PLAIN NIACIN IN THE MANAGEMENT OF HYPERLIPIDEMIA, Metabolism, clinical and experimental, 47(9), 1998, pp. 1097-1104
Authors:
SUPERKO HR
BLANCHE P
HOLL L
ORR J
SCHOENFELD MJ
KRAUSS RM
Citation: Hr. Superko et al., REDUCTION IN PLASMA LDL AND APO-B LEVELS WITH COMBINED ESTROGEN PLUS PROGESTIN THERAPY IN POSTMENOPAUSAL WOMEN IS GREATER IN WOMEN WITH DENSE RATHER THAN BUOYANT LDL, Circulation, 98(17), 1998, pp. 33-33
Authors:
SUPERKO HR
Citation: Hr. Superko, DID GRANDMA GIVE YOU HEART-DISEASE - THE NEW BATTLE AGAINST CORONARY-ARTERY DISEASE, The American journal of cardiology, 82(9A), 1998, pp. 34-46
Authors:
GUYTON JR
GOLDBERG AC
KREISBERG RA
SPRECHER DL
SUPERKO HR
OCONNOR CM
Citation: Jr. Guyton et al., EFFECTIVENESS OF ONCE-NIGHTLY DOSING OF EXTENDED-RELEASE NIACIN ALONEAND IN COMBINATION FOR HYPERCHOLESTEROLEMIA, The American journal of cardiology, 82(6), 1998, pp. 737-743
Authors:
SUPERKO HR
Citation: Hr. Superko, INCLUSION OF LIPOPROTEIN SUBFRACTIONS AMONG EFFICACY PARAMETERS, The American journal of cardiology, 81(8A), 1998, pp. 52-55
Authors:
SUPERKO HR
KRAUSS RM
Citation: Hr. Superko et Rm. Krauss, LDL SUBCLASS DISTRIBUTION CHANGE IN FAMILIAL COMBINED HYPERLIPIDEMIA PATIENTS FOLLOWING GEMFIBROZIL AND NIACIN TREATMENT, Journal of the American College of Cardiology, 29(2), 1997, pp. 92191-92191
Authors:
SUPERKO HR
Citation: Hr. Superko, THE NEW THINKING ON LIPIDS AND CORONARY-ARTERY DISEASE, Current opinion in cardiology, 12(2), 1997, pp. 180-187
Authors:
GUYTON JR
OCONNOR CM
GOLDBERG AC
KREISBERG RA
SPRECHER DL
SUPERKO HR
Citation: Jr. Guyton et al., EXTENDED-RELEASE NIACIN WITH OR WITHOUT INHIBITORS OF HYDROXYMETHYLGLUTARYL COA REDUCTASE - IMPROVEMENT IN DYSLIPIDEMIA WITH MINIMAL EFFECTON TRANSAMINASES, Atherosclerosis, 134(1-2), 1997, pp. 56-56
Authors:
DUNN PL
SUPERKO HR
MEESE RB
WILLIAMS P
Citation: Pl. Dunn et al., CARDIOVASCULAR RISK REDUCTION IS COST-EFFECTIVE IN THE REAL-WORLD, Circulation, 96(8), 1997, pp. 365-365
Authors:
SUPERKO HR
KRAUSS RM
ALDERMAN EL
Citation: Hr. Superko et al., DIABETICS HAVE RAPID ARTERIOGRAPHIC CORONARY-DISEASE PROGRESSION BUT ALSO ARTERIOGRAPHIC BENEFIT FROM RISK REDUCTION, Circulation, 96(8), 1997, pp. 4289-4289
Authors:
SUPERKO HR
KRAUSS RM
DIRICCO C
Citation: Hr. Superko et al., EFFECT OF FLUVASTATIN ON LOW-DENSITY-LIPOPROTEIN PEAK PARTICLE DIAMETER, The American journal of cardiology, 80(1), 1997, pp. 78
Authors:
SUPERKO HR
Citation: Hr. Superko, ELEVATED HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL, NOT PROTECTIVE IN THE PRESENCE OF HOMOCYSTEINEMIA, The American journal of cardiology, 79(5), 1997, pp. 705-706
Authors:
FORRESTER JS
MERZ CNB
BUSH TL
COHN JN
HUNNINGHAKE DB
PARTHASARATHY S
SUPERKO HR
Citation: Js. Forrester et al., TASK-FORCE 4 - EFFICACY OF RISK FACTOR MANAGEMENT, Journal of the American College of Cardiology, 27(5), 1996, pp. 991-1006
Authors:
SUPERKO HR
Citation: Hr. Superko, COST-EFFECTIVE TREATMENT OF CORONARY-ARTERY DISEASE - THE NEW IMPERATIVE, Clinical cardiology, 19(8), 1996, pp. 650-655
Authors:
SUPERKO HR
Citation: Hr. Superko, LIPID DISORDERS CONTRIBUTING TO CORONARY HEART-DISEASE - AN UPDATE, Current problems in cardiology, 21(11), 1996, pp. 738-780
Authors:
SUPERKO HR
Citation: Hr. Superko, BEYOND LDL CHOLESTEROL REDUCTION, Circulation, 94(10), 1996, pp. 2351-2354
Authors:
SUPERKO HR
Citation: Hr. Superko, NEW ASPECTS IN LIPIDOLOGY AND ATHEROSCLEROSIS, Canadian journal of cardiology, 11, 1995, pp. 4-8
Authors:
SUPERKO HR
Citation: Hr. Superko, SOPHISTICATED PRIMARY AND SECONDARY ATHEROSCLEROSIS PREVENTION IS COST-EFFECTIVE, Canadian journal of cardiology, 11, 1995, pp. 35-40
Authors:
SUPERKO HR
Citation: Hr. Superko, NEW ASPECTS OF RISK-FACTORS FOR THE DEVELOPMENT OF ATHEROSCLEROSIS, INCLUDING SMALL LOW-DENSITY-LIPOPROTEIN, HOMOCYST(E)INE, AND LIPOPROTEIN(A), Current opinion in cardiology, 10(4), 1995, pp. 347-354
Authors:
SUPERKO HR
ORR JR
KRAUSS RM
Citation: Hr. Superko et al., REDUCTION OF SMALL, DENSE LDL BY GEMFIBROZIL IN LDL SUBCLASS PATTERN-B, Circulation, 92(8), 1995, pp. 1194-1194
Authors:
SUPERKO HR
Citation: Hr. Superko, FAILURE OF CHOLESTEROL TREATMENT IN PATIENTS WITH CORONARY-ARTERY DISEASE - A COST-EFFECTIVE SOLUTION, The American journal of cardiology, 75(4), 1995, pp. 277-277
Authors:
SUPERKO HR
WOOD PD
KRAUSS RM
Citation: Hr. Superko et al., OPPOSITE EFFECTS OF ALPHA AND BETA-ADRENERGIC BLOCKERS ON LDL SUBCLASS DISTRIBUTION IN HYPERTENSIVE SUBJECTS, Circulation, 90(4), 1994, pp. 471-471
Authors:
SUPERKO HR
WOOD PD
KRAUSS RM
Citation: Hr. Superko et al., OPPOSITE EFFECTS OF ALPHA AND BETA-ADRENERGIC BLOCKERS ON LDL SUBCLASS DISTRIBUTION IN HYPERTENSIVE SUBJECTS, Circulation, 90(4), 1994, pp. 471-471
Authors:
SUPERKO HR
Citation: Hr. Superko, EFFECT OF NICOTINIC-ACID ON LDL SUBCLASS PATTERNS, Circulation, 90(4), 1994, pp. 504-504
Authors:
SUPERKO HR
Citation: Hr. Superko, EFFECT OF NICOTINIC-ACID ON LDL SUBCLASS PATTERNS, Circulation, 90(4), 1994, pp. 504-504